Warby Parker Inc.

NYSE:WRBY

Medical - Instruments & Supplies

Healthcare
$28.22 +3.78%

+$0.92 today

Market cap
$3.07B
Beta
1.97
P/E (TTM)
2305.1
EPS (TTM)
$0.01
52W Low $14.96High $31.00

Volume 5.90M

Average 2.81M

WRBY Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Warby Parker Inc.NYSE: WRBY

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue dips below year-ago levels

Q2 FY2026 cost of revenue of $99.05M fell 1.8% year over year, behind the +10.5% change in trailing-twelve-month cost of revenue. Sequentially, it fell 11.1% from the prior quarter. Over 3 fiscal years it compounded at +16.0% a year.

Context

  • Cost of revenue amounted to 46.0% of revenue in FY2025, up 1.4 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -1.8% toward the trailing-twelve-month pace of +10.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$99.05M-11.1% QoQ
Last fiscal yearDec 2025
$401.33M+16.5% YoY
LTMJun 2026
$413.12M+10.5% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.8%——
1 year+16.5%——
3-year CAGR+16.0%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
401.33M USD
Year-over-year change
+16.5%
4-year CAGR
+15.8%

Cost of Revenue vs competitors

How WRBY compares with its peers on the latest reported figures

  • WRBY's LTM Jun 2026 cost of revenue of $413.12M is the 8th highest of the 10 companies compared; the peer median is $1.4B.
  • Its year-over-year change of +10.5% is the highest of 9, against a peer median of +2.3%.
  • Cost of revenue amounts to 45.3% of revenue for WRBY, versus a peer median of 51.1%.
WRBY Competitors Peer median
Cost of Revenue for WRBY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BHCBausch Health Companies Inc.LTM Jun 2026$3.06B +5.9%+8.4%28.2%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$1.88B +4.4%+0.8%51.1%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$1.64B +9.4%+5.6%70.1%
QDELQuidelOrtho CorporationLTM Mar 2026$1.46B -0.3%+3.1%55.0%
ITGRInteger Holdings CorporationLTM Jul 2026$1.4B +4.6%+13.0%76.3%
ICUIICU Medical, Inc.LTM Jun 2026$1.35B -11.4%-3.8%62.4%
HAEHaemonetics CorporationLTM Jun 2026$576.17M -0.9%+2.7%42.6%
WRBYWarby Parker Inc.LTM Jun 2026$413.12M +10.5%+16.0%45.3%
LMATLeMaitre Vascular, Inc.LTM Mar 2026$70.77M +0.2%+7.8%27.6%
BEAMBeam Therapeutics Inc.LTM Jun 2026$0 —-58.5%0.0%
Peer median (excluding WRBY) $1.4B+2.3%+3.1%51.1%

Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue540.8M598.11M669.77M771.32M871.91M
Cost of Revenue223.05M257.05M304.54M344.48M401.33M
Gross Profit317.75M341.06M365.22M426.83M470.58M
Gross Margin58.8%57.0%54.5%55.3%54.0%
Research & Development00000
Selling, General & Admin461.41M452.27M421.57M440.05M475.92M
Operating Expenses461.41M452.27M437.22M456.95M475.92M
Depreciation & Amortization21.87M31.86M38.55M45.87M50.28M
EBITDA(122.14M)(78.03M)(24.21M)26.35M53.32M
EBITDA Margin-22.6%-13.0%-3.6%3.4%6.1%
Operating Income(143.66M)(111.2M)(72M)(30.11M)(5.34M)
Operating Margin-26.6%-18.6%-10.7%-3.9%-0.6%
Interest Income01.31M9.23M10.6M8.38M
Interest Expense347K0000
Other Income / Expenses(347K)1.31M9.23M10.6M8.38M
Income Before Tax(144.01M)(109.9M)(62.76M)(19.52M)3.04M
Pre-Tax Margin-26.6%-18.4%-9.4%-2.5%0.3%
Income Tax Expense263K497K433K875K1.4M
Net Income(144.27M)(110.39M)(63.2M)(20.39M)1.64M
Net Margin-26.7%-18.5%-9.4%-2.6%0.2%
EPS (Basic)(1.39)(0.96)(0.54)(0.17)0.01
EPS (Diluted)(1.39)(0.96)(0.54)(0.17)0.01
Weighted Avg Shares113.62M114.94M117.39M120.39M122.67M
Weighted Avg Shares (Diluted)113.62M114.94M117.39M120.39M125.1M

Warby Parker Inc.

NYSE:WRBY

Intrinsic Alpha fair value

Locked

Current Price

$28.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.